Erythrocytic G6PD dehydrogenase assay

An internal standard for the quantification of DGLA by GC- or LC-MS.

An internal standard for the quantification of DGLA by GC- or LC-MS.

DO-264 is a selective and in vivo-active inhibitor of Abhydrolase Domain Containing 12 ( ABHD12 ), with an IC 50 of 11 nM.In VitroDO-264 displays an IC 50 value of 11 nM (9.6 nM-13 nM). DO-264 blocks lyso-PS hydrolysis activities of recombinant

For quantitative determination of glucose-6-phosphate in biological samples. Linear detection range 10 to 1000 &muM G6P.

Antibodies are produced in rabbits by immunization with equine immunoglobulins and formulated with selected &beta globulins including the C3 component of complement. The resulting antiserum is heated at 56&degC for 30 minutes to inactivate rabbit

DescriptionGlucose 6-phosphate (G6P) is a key metabolic intermediate that enters either metabolic pathways or storage. G6P is generated when glucose is phosphorylated by hexokinase or glucokinase or by the conversion of glucose-1-phosphate by

Glucose-6-Phosphate Dehydrogenase (G6PD)

Glucose-6-Phosphate Dehydrogenase (G6PD)

Glucose-6-Phosphate Dehydrogenase (G6PD)

Glucose-6-Phosphate Dehydrogenase (G6PD)

DescriptionGlucose-6-phosphate dehydrogenase (G6PDH) catalyzes the conversion of glucose-6-phosphate to 6-phosphoglucono-δ-lactone, the first and rate-limiting step of the pentose phosphate pathway (PPP). The PPP pathway critical for maintaining the

Glucose 6-phosphate dehydrogenase (G-6-P-DH) is a key regulatory enzyme in the first step of the pentose phosphate pathway. G-6-P-DH is a glycoprotein with a molecular mass of 128 kDa (gel filtration).